Václavíková R - Search Results

1

The anticancer drug ellipticine is a potent inducer of rat cytochromes P450 1A1 and 1A2, thereby modulating its own metabolism.

Aimová D, Svobodová L, Kotrbová V, Mrázová B, Hodek P, Hudecek J, Václavíková R, Frei E, Stiborová M. Aimová D, et al. Among authors: vaclavikova r. Drug Metab Dispos. 2007 Oct;35(10):1926-34. doi: 10.1124/dmd.107.016048. Epub 2007 Jul 26. Drug Metab Dispos. 2007. PMID: 17656468

2

Different in vitro metabolism of paclitaxel and docetaxel in humans, rats, pigs, and minipigs.

Vaclavikova R, Soucek P, Svobodova L, Anzenbacher P, Simek P, Guengerich FP, Gut I. Vaclavikova R, et al. Drug Metab Dispos. 2004 Jun;32(6):666-74. doi: 10.1124/dmd.32.6.666. Drug Metab Dispos. 2004. PMID: 15155559

3

Metabolism of new-generation taxanes in human, pig, minipig and rat liver microsomes.

Gut I, Ojima I, Vaclavikova R, Simek P, Horsky S, Linhart I, Soucek P, Kondrova E, Kuznetsova LV, Chen J. Gut I, et al. Among authors: vaclavikova r. Xenobiotica. 2006 Sep;36(9):772-92. doi: 10.1080/00498250600829220. Xenobiotica. 2006. PMID: 16971343

4

Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants.

Václavíková R, Horský S, Simek P, Gut I. Václavíková R, et al. Naunyn Schmiedebergs Arch Pharmacol. 2003 Sep;368(3):200-9. doi: 10.1007/s00210-003-0781-9. Epub 2003 Aug 14. Naunyn Schmiedebergs Arch Pharmacol. 2003. PMID: 12920504

5

Effects of paclitaxel, docetaxel and their combinations on subcutaneous lymphomas in inbred Sprague-Dawley/Cub rats.

Otová B, Václavíková R, Danielová V, Holubová J, Ehrlichová M, Horský S, Soucek P, Simek P, Gut I. Otová B, et al. Among authors: vaclavikova r. Eur J Pharm Sci. 2006 Dec;29(5):442-50. doi: 10.1016/j.ejps.2006.08.007. Epub 2006 Aug 23. Eur J Pharm Sci. 2006. PMID: 17000091

6

The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patients.

Hlaváč V, Brynychová V, Václavíková R, Ehrlichová M, Vrána D, Pecha V, Trnková M, Kodet R, Mrhalová M, Kubáčková K, Gatěk J, Vážan P, Souček P. Hlaváč V, et al. Among authors: vaclavikova r. Medicine (Baltimore). 2014 Dec;93(28):e255. doi: 10.1097/MD.0000000000000255. Medicine (Baltimore). 2014. PMID: 25526449 Free PMC article.

7

The role of membrane transporters in ovarian cancer chemoresistance and prognosis.

Cerovska E, Elsnerova K, Vaclavikova R, Soucek P. Cerovska E, et al. Among authors: vaclavikova r. Expert Opin Drug Metab Toxicol. 2017 Jul;13(7):741-753. doi: 10.1080/17425255.2017.1332179. Epub 2017 May 29. Expert Opin Drug Metab Toxicol. 2017. PMID: 28511565 Review.

8

Role of Genetic Variation in Cytochromes P450 in Breast Cancer Prognosis and Therapy Response.

Hlaváč V, Václavíková R, Brynychová V, Ostašov P, Koževnikovová R, Kopečková K, Vrána D, Gatěk J, Souček P. Hlaváč V, et al. Among authors: vaclavikova r. Int J Mol Sci. 2021 Mar 10;22(6):2826. doi: 10.3390/ijms22062826. Int J Mol Sci. 2021. PMID: 33802237 Free PMC article. Clinical Trial.

9

Cell death induced by taxanes in breast cancer cells: cytochrome C is released in resistant but not in sensitive cells.

Ehrlichová M, Koc M, Truksa J, Naldová Z, Václavíková R, Kovárr J. Ehrlichová M, et al. Among authors: vaclavikova r. Anticancer Res. 2005 Nov-Dec;25(6B):4215-24. Anticancer Res. 2005. PMID: 16309219 Free article.

10

RNA expression of cytochrome P450 in breast cancer patients.

Vaclavikova R, Hubackova M, Stribrna-Sarmanova J, Kodet R, Mrhalova M, Novotny J, Gut I, Soucek P. Vaclavikova R, et al. Anticancer Res. 2007 Nov-Dec;27(6C):4443-50. Anticancer Res. 2007. PMID: 18214058 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters